{"id":"https://openalex.org/W2460201367","doi":null,"title":"[Opiate addiction. Pharmacologic and biochemical aspects].","display_name":"[Opiate addiction. Pharmacologic and biochemical aspects].","publication_year":1992,"publication_date":"1992-02-01","ids":{"openalex":"https://openalex.org/W2460201367","mag":"2460201367","pmid":"https://pubmed.ncbi.nlm.nih.gov/1586396"},"language":"de","primary_location":{"id":"pmid:1586396","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1586396","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arzneimittel-Forschung","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111312287","display_name":"A. Herz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145969","display_name":"Max Planck Institute of Psychiatry","ror":"https://ror.org/04dq56617","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210145969"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"A Herz","raw_affiliation_strings":["Abteilung Neuropharmakologie, Max-Planck-Instituts f\u00fcr Psychiatrie, M\u00fcnchen-Martinsried"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abteilung Neuropharmakologie, Max-Planck-Instituts f\u00fcr Psychiatrie, M\u00fcnchen-Martinsried","institution_ids":["https://openalex.org/I4210145969"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045595920","display_name":"Toni Shaun Shippenberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T S Shippenberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000613389","display_name":"Regine Bals-Kubik","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Bals-Kubik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5016315764","display_name":"Rainer Spanagel","orcid":"https://orcid.org/0000-0003-2151-4521","observed_orcids":["https://orcid.org/0000-0003-2151-4521"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Spanagel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2463,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.48686476,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"42","issue":"2A","first_page":"256","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.5781000256538391,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.5781000256538391,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.41260001063346863,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9829999804496765},{"id":"https://openalex.org/keywords/mu-opioid-receptor","display_name":"mu-opioid receptor","score":0.7680000066757202},{"id":"https://openalex.org/keywords/kappa-opioid-receptor","display_name":"kappa opioid receptor","score":0.9430000185966492},{"id":"https://openalex.org/keywords/delta-opioid-receptor","display_name":"delta opioid receptor","score":0.9160000085830688},{"id":"https://openalex.org/keywords/conditioned-place-preference","display_name":"conditioned place preference","score":0.8080000281333923},{"id":"https://openalex.org/keywords/conditioned-place-aversion","display_name":"conditioned place aversion","score":0.9020000100135803},{"id":"https://openalex.org/keywords/mesolimbic-dopamine-system","display_name":"mesolimbic dopamine system","score":0.9589999914169312},{"id":"https://openalex.org/keywords/nucleus-accumbens","display_name":"nucleus accumbens","score":0.8489999771118164},{"id":"https://openalex.org/keywords/dopamine-release","display_name":"dopamine release","score":0.7459999918937683},{"id":"https://openalex.org/keywords/beta-endorphin","display_name":"beta-endorphin","score":0.7910000085830688},{"id":"https://openalex.org/keywords/dynorphin","display_name":"dynorphin","score":0.9779999852180481},{"id":"https://openalex.org/keywords/endogenous-opioid-system","display_name":"endogenous opioid system","score":0.8410000205039978},{"id":"https://openalex.org/keywords/microdialysis","display_name":"microdialysis","score":0.734000027179718},{"id":"https://openalex.org/keywords/microinjection","display_name":"microinjection","score":0.6449999809265137}],"concepts":[{"id":"https://openalex.org/C2776552330","wikidata":"https://www.wikidata.org/wiki/Q1476178","display_name":"Nucleus accumbens","level":3,"score":0.8351846933364868},{"id":"https://openalex.org/C151077648","wikidata":"https://www.wikidata.org/wiki/Q324076","display_name":"Dynorphin","level":5,"score":0.646241307258606},{"id":"https://openalex.org/C2777650357","wikidata":"https://www.wikidata.org/wiki/Q1569460","display_name":"Mesolimbic pathway","level":5,"score":0.6411195993423462},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5498629808425903},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.548852264881134},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.528306245803833},{"id":"https://openalex.org/C24566897","wikidata":"https://www.wikidata.org/wiki/Q943621","display_name":"Tegmentum","level":4,"score":0.5262980461120605},{"id":"https://openalex.org/C184389661","wikidata":"https://www.wikidata.org/wiki/Q14897645","display_name":"\u03ba-opioid receptor","level":4,"score":0.4807853102684021},{"id":"https://openalex.org/C50156730","wikidata":"https://www.wikidata.org/wiki/Q3856966","display_name":"Microdialysis","level":3,"score":0.4747507870197296},{"id":"https://openalex.org/C3017995582","wikidata":"https://www.wikidata.org/wiki/Q417189","display_name":"Endogenous opioid","level":4,"score":0.45920923352241516},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44288545846939087},{"id":"https://openalex.org/C14397066","wikidata":"https://www.wikidata.org/wiki/Q14911924","display_name":"\u03bc-opioid receptor","level":4,"score":0.4105337858200073},{"id":"https://openalex.org/C2780948874","wikidata":"https://www.wikidata.org/wiki/Q640562","display_name":"Ventral tegmental area","level":4,"score":0.4038217067718506},{"id":"https://openalex.org/C88016717","wikidata":"https://www.wikidata.org/wiki/Q417189","display_name":"Opioid peptide","level":4,"score":0.34493374824523926},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34023746848106384},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.33018261194229126},{"id":"https://openalex.org/C552161191","wikidata":"https://www.wikidata.org/wiki/Q185080","display_name":"Midbrain","level":3,"score":0.3299649953842163},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3143653869628906},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.27600377798080444},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23385193943977356},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.23379430174827576},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.231864333152771}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:1586396","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1586396","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arzneimittel-Forschung","raw_type":"English Abstract"},{"id":"mag:2460201367","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1586396","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2133672910","https://openalex.org/W2040873559","https://openalex.org/W4246471724","https://openalex.org/W1989201294","https://openalex.org/W2120086482","https://openalex.org/W7097081147","https://openalex.org/W2401841998","https://openalex.org/W2126888123","https://openalex.org/W2253937444","https://openalex.org/W2083585149"],"abstract_inverted_index":{"The":[0],"detailed":[1],"information":[2],"now":[3],"available":[4],"regarding":[5],"the":[6,30,83,90,106,132,145,157,161,171,181],"neurobiology":[7],"of":[8,17,29,124,134,160,175,180],"opiates":[9],"(opioids)":[10],"has":[11,23],"contributed":[12],"greatly":[13],"to":[14,122],"our":[15],"understanding":[16,28],"opioid":[18,138],"addiction.":[19,34],"This":[20],"in":[21,62,89,105,120,144,156,170],"turn":[22],"permitted":[24],"a":[25,38,148,177],"more":[26],"complete":[27],"processes":[31],"underlying":[32],"drug":[33],"Opioid":[35],"agonists":[36,111],"with":[37,53,82],"high":[39],"affinity":[40],"for":[41,48,127],"mu-":[42],"or":[43],"delta-receptors":[44],"produce":[45],"conditioned":[46],"preferences":[47],"an":[49,80,164],"environment":[50],"previously":[51],"associated":[52],"their":[54],"administration,":[55],"whereas":[56,109],"kappa-agonists":[57],"induce":[58],"place":[59],"aversions.":[60],"Studies":[61],"which":[63,140],"opioids":[64,186],"were":[65],"microinjected":[66],"into":[67],"discrete":[68],"brain":[69],"areas":[70],"suggest":[71],"that":[72,97],"these":[73,128],"opposing":[74],"motivational":[75],"effects":[76,115],"are":[77,118,187],"mediated":[78,153,167],"via":[79],"interaction":[81],"mesolimbic":[84,146,182],"dopamine":[85],"(DA)":[86],"system":[87,183],"originating":[88],"midbrain.":[91],"Microdialysis":[92],"studies":[93],"have":[94],"clearly":[95],"shown":[96],"mu-agonists":[98],"preferentially":[99],"increase":[100],"DA":[101,117,142],"release":[102,143],"and":[103,163],"metabolism":[104],"Nucleus":[107,172],"accumbens,":[108],"kappa-receptor":[110],"decrease":[112],"release.":[113],"Opposite":[114],"on":[116],"observed":[119],"response":[121],"microinjections":[123],"selective":[125],"antagonists":[126],"receptor":[129],"types,":[130],"suggesting":[131],"existence":[133],"tonically":[135],"active":[136],"endogenous":[137,185],"systems":[139],"maintain":[141],"system:":[147],"continuous":[149],"\"reward\"":[150],"tone,":[151,166],"probably":[152],"by":[154,168,184],"beta-endorphin":[155],"ventral":[158],"tegmentum":[159],"midbrain":[162],"\"aversive\"":[165],"dynorphin":[169],"accumbens.":[173],"Aspects":[174],"such":[176],"bidirectional":[178],"regulation":[179],"discussed.":[188]},"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-07-22T00:00:00"}